We are live on ! Find out more
JGUA

John G. Ullman & Associates Portfolio holdings

AUM $754M
1-Year Est. Return 60.05%
This Fund
S&P 500
This Quarter Est. Return
+10.76%
1 Year Est. Return
+60.05%
3 Year Est. Return
+108.28%
5 Year Est. Return
+118.76%
10 Year Est. Return
+308.24%
AUM
$745M
AUM Growth
+$100M
Cap. Flow
+$33.5M
Cap. Flow %
4.49%
Top 10 Hldgs %
32.1%
Holding
165
New
13
Increased
37
Reduced
77
Closed
11

Top Sells

Rank Stock Value
1
ABT icon
Abbott
ABT
+$4.4M
2
TDC icon
Teradata
TDC
+$3.37M
3
ALB icon
Albemarle
ALB
+$3.15M
4
LNN icon
Lindsay Corp
LNN
+$2.9M
5
CTVA icon
Corteva
CTVA
+$2.5M

Sector Composition

Rank Sector Weight
1 Healthcare 23.6%
2 Technology 23.47%
3 Industrials 19.04%
4 Utilities 16.65%
5 Communication Services 7.77%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CTVA icon
151
Corteva
CTVA
$51.3B
-64,686
Closed -$2.5M
MU icon
152
Micron Technology
MU
$991B
-4,863
Closed -$366K
TDC icon
153
Teradata
TDC
$2.55B
-150,051
Closed -$3.37M
VHT icon
154
Vanguard Health Care ETF
VHT
$18.6B
-1,000
Closed -$224K
VMC icon
155
Vulcan Materials
VMC
$36.9B
-2,000
Closed -$297K
AEGN
156
DELISTED
Aegion Corp
AEGN
-11,500
Closed -$218K

Similar funds

John G. Ullman & Associates's Q1 2021 Portfolio in Review

As of Q1 2021, John G. Ullman & Associates held 165 positions worth $745M, up 16% from $645M the previous quarter. Its ten largest holdings account for 32% of the portfolio.

John G. Ullman & Associates deployed $33.5M of net new capital in Q1 2021, opening 13 new positions and adding to 37 existing holdings. Its largest new stake was American Tower: 11,570 shares worth $2.77M.

By sector, the portfolio is most concentrated in Healthcare at 24% of assets, down from 26% a quarter earlier, followed by Technology and Industrials.

On the sell side, the largest reduction was Abbott, an estimated $4.4M trimmed.

  • John G. Ullman & Associates's largest Q1 2021 buy was American Tower: 11,570 shares worth $2.77M.
  • John G. Ullman & Associates added most to Verizon in Q1 2021, an estimated $10.3M increase.
  • John G. Ullman & Associates's biggest Q1 2021 reduction was Abbott, cutting an estimated $4.4M.
  • John G. Ullman & Associates fully exited Teradata in Q1 2021, selling an estimated $3.37M.
  • John G. Ullman & Associates's ten largest holdings make up 32% of its $745M portfolio in Q1 2021.
  • John G. Ullman & Associates opened 13 new positions and closed 11 in Q1 2021.
  • John G. Ullman & Associates's portfolio value rose 16% quarter-over-quarter to $745M.

Based on John G. Ullman & Associates's 13F filing for Q1 2021, filed 22 Apr 2021.